MedinCell S.A.
MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
MedinCell S.A. (MDCLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDCLF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $25.54M | $9.16M | $9.94M | $4.09M | $8.19M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $1.45M |
| Gross Profit | $25.54M | $9.16M | $9.94M | $4.09M | $6.74M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 82.27% |
| Operating Expenses | |||||
| R&D Expenses | $24.31M | $21.08M | $27.93M | $23.61M | $18.50M |
| G&A Expenses | $0.00M | $9.15M | $7.13M | $6.21M | $5.64M |
| Total Operating Expenses | $36.38M | $30.14M | $33.99M | $27.90M | $22.34M |
| Operating Income | ($10.84M) | ($20.98M) | ($24.02M) | ($23.81M) | ($15.61M) |
| Operating Margin %(computed) | -42.44% | -229.01% | -241.60% | -582.25% | -190.65% |
| Interest Income | $0.00M | ($0.04M) | $0.00M | $0.05M | $0.02M |
| Interest Expense | $5.09M | $4.62M | $3.93M | $1.84M | $2.27M |
| Income Before Tax | ($18.28M) | ($24.95M) | ($32.01M) | ($24.81M) | ($20.43M) |
| Income Tax Expense | $0.16M | $0.09M | $0.00M | $0.00M | ($1.45M) |
| Net Income | ($18.44M) | ($25.04M) | ($32.01M) | ($24.81M) | ($19.02M) |
| Net Margin %(computed) | -72.19% | -273.34% | -321.90% | -606.50% | -232.35% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.63 | $-0.88 | $-1.27 | $-1.00 | $-0.86 |
| Wtd Avg Shares | 29.10M | 28.42M | 25.19M | 24.87M | 22.04M |
| EBITDA | ($11.20M) | ($18.61M) | ($26.41M) | ($21.45M) | ($15.38M) |
| EBITDA Margin %(computed) | -43.85% | -203.21% | -265.62% | -524.35% | -187.87% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M
Explore more MedinCell S.A. data
About MedinCell S.A. (MDCLF) Income Statement
MedinCell S.A. (MDCLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MDCLF reported revenue of $0.03B, gross profit of $0.03B (gross margin 100.00%), and net income of ($0.02B) — a net profit margin of -72.19%.
Frequently asked questions
MDCLF · 4 questionsMedinCell S.A. (MDCLF) reported revenue of $0.03B for 2025, up 178.8% year-over-year.
MDCLF revenueMDCLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09